It also induces apoptosis, even in MGMT+ GBM cells, through modulation of Wnt/β-catenin and Akt/NF-κB pathways, highlighting its potential to overcome resistance mechanisms [94]. The gene discussed is AKT1; the disease is glioblastoma.